RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 81 filers reported holding RECRO PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 1,104,546 | $11,233,000 | 5.38% |
| Broadfin Capital, LLC | 1,561,617 | $15,882,000 | 3.46% |
| Corsair Capital Management | 742,900 | $7,555,000 | 2.21% |
| NORTH RUN CAPITAL, LP | 315,338 | $3,207,000 | 2.18% |
| Fondren Management LP | 95,000 | $966,000 | 0.92% |
| Leap Investments LP | 25,611 | $260,000 | 0.35% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 213,002 | $2,166,000 | 0.30% |
| Campbell & CO Investment Adviser LLC | 38,989 | $397,000 | 0.18% |
| Opus Point Partners Management, LLC | 11,353 | $115,000 | 0.17% |
| Penn Capital Management Company, LLC | 149,946 | $1,525,000 | 0.15% |